Trent

YEAR                       EVENTS
 1952 - The Company was incorporated on 5th December, at Mumbai.  It
        manufactures cosmetics, perfumery, toilet preparations, basic
        drugs, drug intermediates and formulations thereof.
 
 1978 - 20,000 bonus shares issued in prop. 4:5.
 
 1981 - 36,000 bonus shares issued in prop. 4:5.
 
 1982 - The Tata Oil Mills Co. Ltd., offered for sale 4,17,000 No. of
        equity shares of Rs 10 each of the Company at a premium of Rs
 10
        per share.
 
      - 5,00,000 shares of Rs 10 each then issued (prem. Rs 10 per
 share)
        of which 40,000 shares reserved for preferential allotment to
 the
        employees/business associates of the Company.  The balance
        4,60,000 shares (along with reserved quota not taken up if
 any)
        offered for public subscription during December.
 
 1985 - In May/June, in order to augment the long-term resources for
        working capital requirements, the Company issued 15%
        non-convertible secured debentures of Rs 100 each of the
        aggregate value of Rs 1.25 crores on `Rights basis' in the
        proportion of one debenture for every 10 equity shares held.
        These debentures are redeemable at a premium of Rs 5 per share
 on
        the expiry of seven years from the date of allotment.
 
      - The Company received separate industrial licence for the
        manufacture and exports of various types of medical equipment
        from Kandla Free Trade Zone.
 
      - Application was also made for conversion of the letter of
 intent
        into Industrial Licence in respect of the project for the
        manufacture of pharmaceutical formulations.
 
      - 5,24,000 bonus shares issued in prop. 2:5 in March 1986.
 
 1986 - Two separate undertakings were established for the manufacture
 of
        medical equipments and pharmaceutical formulations
 respectively 
        at the Kandla Free Trade Zone.
 
      - The Company issued 2,75,000-13.5% secured redeemable
 convertible
        debentures of Rs 100 each as follows: (i) 2,62,000 debentures
 to
        the existing equity shares holders on rights basis in the
 ratio
        of 1 debenture for 7 equity shares held and (ii) 13,000
        debentures to the employees/workers on equitable basis.
 
      - Out of the employees' quota only 7,690 debentures were taken
 up
        and the balance 5,310 debentures were allowed to lapse.  Thus
 a
        total of 2,69,690 debentures were allotted.
 
      - A portion of Rs 25 of each debenture was compulsorily
 converted
        into 1 equity share of Rs 10 each at a premium of Rs 15 on
 the
        expiry of 1 year from the date of allotment.  The remaining
        portion of Rs 75 of each debenture, after conversion, would
 be
        redeemed at par at the end of 7 years from the date of
 allotment.
 
 1988 - The cosmetics division launched two new products which were
 well
        received in the market.
 
      - The Company's industrial undertakings at Kandla Free Trade
 Zone
        (KAFTZ) Gandhidham, Kutch, Gujarat, engaged exclusively in
        exports, was sold as a going concern to the Company's wholly
        owned subsidiary `Lakme Exports Ltd.'  Lakme Exports Ltd.,
 were
        also to take over the services of all employees at KAFTZ.
 
 1989 - 10,04,437 No. of equity shares issued (prem. Rs 75 per share)
 as
        rights and to employees.  Another 1,04,500 No. of equity
 shares
        of Rs 10 each allotted as fully paid up to the shareholders
 of
        Bruel Investments Ltd.
 
 1991 - The Company has initiated steps to enhance its exports to
 general
        currency area.  The Pharmaceuticals division continued to be
        affected by high cost of raw materials without any
 commensurate
        increase in the selling prices.
 
      - The Breul Investments Ltd. has become a subsidiary of the
        Company.
 
 1992 - Breul Investments Ltd. was amalgamated with the Company with
        effect from 1st April.  As per the terms of scheme 1,04,500
 No.
        of equity shares of Rs 10 each of the Company were allotted
 to
        the shareholders of BIL in the portion of 55 No. of equity
 shares
        of the Company for each share held in BIL.
 
 1994 - The new products introduced by the Cosmetics divisions viz.,
        Ultra and the Orchids ranges in colour cosmetics fields were
        well received in the market.
 
      - With a view to focus and concentrate on the core business of
        cosmetics and personal care products and ensure growth of
 pharm
        business, the Company decided to restructure the business by
        selling the pharmaceutical division called the Tata Pharma to
 a
        proposed new Company called Tata Pharma Pvt. Ltd.
 
      - Miaami Pharma & Chemicals Ltd. (MPCL), was merged with Lakme
 Ltd.
        effective 1st January, as per the scheme approved by BIFR. 
 On
        9.12.1994, the shareholders of erstwhile MPCL were allotted
 one
        equity share of each of Lakme Ltd., for every 45 shares held
 by
        them in MPCL.  Accordingly, 1,09,333 shares were allotted.
 
 1995 - A new product range `Elle 18' as well as several new products
 and
        variants were introduced during the year and were very well
        received in the market.
 
      - The company formed a joint venture, Lakme Lever Ltd., with
        Hindustan Lever Ltd., to which the Company has transferred
 its
        sales and marketing of cosmetic operations.
 
      - 67,10,707 Bonus shares issued in proportion 1:1.
 
 1996 - On 1st January, the Company has formed a subsidiary, Lakme
 Brands
        Ltd. to acquire all the trade marks, technology, R&D
        infrastructure and brands of the parent Company.
 
 1999 - Name changed to Trent Ltd. with effect from 28-06-1999.
 
 2000 - Lakme has introduced a new range of Lakme Pure Radiance
 Blusher.
 
 2007
 
 -Trent Ltd has entered into an Agreement with The Xander Group Inc.,
 a global private equity firm.